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In the rat model of heterotopic auxiliary liver trans-
plantation (HALTx), the opinion varies on whether
and how the recipient’s native liver should be
handicapped. To avoid atrophy of the transplanted
organ, in this study, two different handicaps were
evaluated and their effects on post-operative animal
survival and liver biology are described. With a sole
portacaval shunt (group 1) all rats survived longer
than 3 months. An additional handicap of the liver
with either a 68% partial hepatectomy (68% PH)
(group 2), or both a 68% PH and a common bile duct
ligation (CBDL) (group 3) led to a 100% mortality
within 2 days after surgery. When an auxiliary liver
was transplanted to the rats handicapped with a 68%
PH (group 4), serum Bilirubin and ALAT values
were significantly lower than those handicapped
with both a 68% PH and a CBDL (group 5). Autopsy
and histology of the long-term survivors revealed
the atrophy of the engrafted livers and the regenera-
tion of the native livers in group 4, whereas it
showed the opposite in group 5. Thus the various
manipulations of the native liver do influence
differently the post-transplant animal survival,
serum liver biochemistry and the outcome of the
engrafted liver in this rat model of HALTx.
Keywords: Heterotopic auxiliary liver transplantation, handi-
cap of the native liver, portacaval shunt, partial hepatectomy,
common bile duct ligation, graft atrophy, inter-liver compe-
tition
INTRODUCTION
In recent years, more and more reports from
different organ-transplantation centers have been
published with encouraging results, using het-
erotopic auxiliary liver transplantation (HALTx)
to treat patients with end-stage liver diseases
especially fulminant and subfulminant hepatic
failure [1- 3]. This has raised a new interest to
study the potential problems of this operative
procedure with animal models [4, 5]. HALTx
in the rat has long been used for experimental
research, since it was first described by Lee
and Edgington in 1966 [6]. The investigators have
used this model to study amongst others, liver
regeneration, hepatotrophic factors, allogenic
microchimerism and graft rejection [5,7,8].
Several technique modifications of this model
have been introduced [9-12].
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Although the observation of graft atrophy
and the concept of "inter-liver competition" in
HALTx were reported in the early 60’s [13-15],
opinion still varies on whether in this rat model
the native liver of the recipient should be
handicapped and in this case which approach
should be used. Some authors handicapped
the native liver either with a 68% partial hepa-
tectomy (68% PH) [7,10] or a 68% PH plus a com-
mon bile duct ligation (CBDL) [9,11]. Others, on
the contrary, left the native liver intact [5, 8,12].
Up to date, there has been no report about
how these different manipulations of the native
liver do influence the post-HALTx animal sur-
vival and serum biochemical values. This was
investigated in the present study.
MATERIALS AND METHODS
Experimental Design (Table)
To evaluate the effects of different handicaps on
the native liver, three experimental groups
were studied, inwhich the livers were put in func-
tionally similar situations as the native livers in
the HALTx model: group 1 (n 10), an end-to-
side portacaval shunt (PCS) (without further
handicap of the liver); group 2 (n 10), a PCS
plus a 68% PH as additional handicap of the
liver; and group 3 (n 10), a PCS, a 68% PH and a
CBDL to handicap the liver.
Two experimental groups were tested later on,
since no long-term survivor and thus serum
biochemical evolution could be obtained from
the rats of groups 2 and 3. In group 4 (n 12), a
HALTx was performed after the native liver was
handicapped in the same way as in group 2 (PCS
and 68% PH). In group 5 (n 12), HALTx was
performed after the handicap of the native liver
as in group 3 (PCS, 68% PH and CBDL).
Experimental Animals
Male Wistar rats weighing 250-340g were
purchased from Janssen Pharmaceutica N.V.,
Belgium. Donor and recipient rats were matched
for size. Rats had free access to food and water
prior to surgery. All animals received humane
care as outlined in the Guide for the Care and Use
of Laboratory Animals (NIH Publication No. 86-
23, revised 1985).
Surgical Techniques
All operations were carried out under ether ana-
esthesia with clean but non sterile instruments
and x 12.5 magnification.
(a) 68% PH: The median lobe and the left lobe
of the liver were ligated and then excised ac-
cording to the standard method introduced
by Higgins and Anderson [16].
(b) CBDL: A segment of the common bile duct
was removed after double ligation.
(c) PCS: The standard method described by Lee
[17] was modified using the cuff technique to
perform a PCS. After a left nephrectomy, the
left renal vein was freed up to the vena cava
which was then cross clamped. An incision
was made into the anterior wall of the stump
of the left renal vein. The portal vein was
divided from the pyloric vein to the liver
hilus, tied, transsected and cuffed with a
0.4cm length polyethylene tube. The cuffed
portal vein was then inserted into the left
renal vein and secured with a 5-0 ligature.
(d) HALTx: The standard technique described
by Marni [9] was used with a slight modi-
fication. After the donor liver was perfused
with heparinized 4C physiological saline
solution via the portal vein, 30% of the liver
was used for transplantation. The native
liver of the recipient rat was handicapped
with a 68% PH or both a 68% PH and a
CBDL according to the study group, while
the hepatic artery remained intact. The
engrafted liver was then implanted in the
right paravertebral gutter under the native
liver of the recipient. The cuff technique
described by Kamada [18] was used for theHANDICAP OF NATIVE LIVER IN RAT HALTx 227
anastomoses of both the vena cava and the
portal vein. The engrafted liver received its
blood supply from the portal vein of-the
recipient. The venous drainage was made
through the right renal vein of the recipient
to the vena cava. Restoration of the bile
drainage was done by insertion of the
intubated common bile duct of the donor
liver into the recipient duodenum. No re-
arterialization was performed. To this stand-
ard procedure, we added a fixation of the
remaining donor diaphragm to the recipient
lateral abdominal wall in order to avoid
twisting and kinking of the donor vena cava.
The duration of the different operative phases
(mainly the portal vein and the vena cava cross-
clamping time) was comparable among groups
1,2 and 3. The cold preservation time of the
grafts (starting from the saline perfusion via the
portal vein ending at the portal re-vasculariza-
tion of the engrafted liver) was kept between 72
and 79 minutes in the rats of HALTx groups 4
and 5.
Post-operative Care
All rats were given 10mg Na Cefazolin intra-
muscularly after the operation and this was
repeated daily for three days. No immunosup-
pressive agent was administered to the rats.
During the following twenty-four hours, rats
were allowed to drink 5% glucose, after which
the pre-operative diet of food pellets and water
was resumed.
Follow-up
Body Weight was recorded daily and survival
time was determined.
For the biochemical analysis, a blood sample
of 0.4-0.5 ml was collected from the tail vein.
Serum total bilirubin (TBil) and alanine amino-
transferase (ALAT) were determined pre-opera-
tively, on post-operative day 3, weekly for one
month and monthly for 3 months.
An autopsy was performed whenever a rat
died to identify possible complications. The
livers were removed at sacrifice and fixed with
10% formalin. Four micron sections were stained
with hematoxylin and eosin (HE) or trichrome.
Liver samples were studied by light microscopy.
Statistical Analysis
The data were expressed as the mean 4-
standard deviation (SD). The Student’s t-test
was used for the data analysis. P values equal to
or less than 0.05 were considered statistically
significant.
RESULTS
Body Weight and Animal Survival
The body weight of all rats declined 24 hours
after the operation with average 10.00 4-
6.47grams per rat in group 4 and 18.334-
14.03 grams in group 5 (NS). Three weeks later,
the rats of group 4 regained their pre-operative
weight and even exceeded up to average
24.074-3.40grams compared with 1.674-11.16
grams in group 5 (NS).
As shown in the Table, the rats of group 1
could well tolerate a PCS whereas all rats in
groups 2 and 3 died of liver failure within two
days after the surgery.
In group 4, the 1-month survival rate was as
high as 92%. Only two rats died of abscess in
the native liver or in both the native and the
engrafted livers on the 17th and 34th post-
operative day. In group 5, only 50% of the
animal survived longer than 3 months. Except a
rat that died of rejection on day 23, all others
died of infectious complications (cholestasis in 1,
abscess in 3 and peritonitis in 1).
Serum Biochemical Parameters
Serum TBil of the rats in group 5 was signifi-
cantly higher than those of group 4 on post-228 Y.-D. FAN et al.
TABLE Experimental groups and post-operative survival
Experimental groups* Survival time
G1 (n 10): PCS
G2 (n 10): PCS + 68% PH
G3 (n 10): PCS+ 68% PH+CBDL
G4 (n 12): .HALTx + 68% PH
G5 (n 12): HALTx+ 68% PH+CBDL
> 3 months (10/10)
0.81 + 0.56 days (mean 4- SD)
0.51 -t- 0.30 days (mean 4- SD)
Survival rates
week 2 weeks 3 weeks month 2 months
100% 100% 92% 92% 83%
100% 83% 58% 50% 50%
PCS: portacaval shunt; 68% PH: 68% partial hepatectomy; CBDL: common bile duct ligation; HALTx: heterotopic auxiliary liver transplantation.
operative day 7 (p=0.025) and 28 (p=0.02)
(Fig. l a). The rats (2#,3#,8
# and 10#) of group 5,
that had the highest values of TBil on day 7,
developed infectious complications and died
within the following weeks. By disregarding
the values of those rats that died of complica-
tions, the differences between the two groups
were still recorded but they were no longer
statistically significant (Fig. lb). The high TBil
peak of group 5 on day 28 was this time due to
the two rats that developed secondary biliary
cirrhosis of the engrafted livers found later at
autopsy.
As showed in Figure 2a, significant differ-
ences of mean serum ALAT between the two
groups were found on day 3 (P=0.014), 21
4- I[G4 (n=12)OG5 (n=12) ]long term survivors G4 (n=10)
long term survivors G5 (n=6)
lb
-1 3 7 14 21 28 56 84 -1 3 14 21 28 56 84
days days
FIGURE Comparison of the mean serum total bilirubin (TBil) between groups 4 and 5 post-HALTx: (a) Data of the whole
group. Statistically significant differences were found on day 7 (p=0.025) and day 28 (p=0.02); (b) Data of the long term
survivors. No significant differences between the two groups could be seen.
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FIGURE 2 Comparison of the mean serum alanine aminotransferase (ALAT) between groups 4 and 5 post-HALTx: (a) Data of
the whole group. The statistically significant differences were found on day 3 (p=0.014), day 21 (p=0.014) and day 28
(p <0.001); (b) Data of the long term survivors. The differences between the two groups was not significant on day 3 and
remained significant on day 21 (p 0.008) and 28 (p < 0.001).HANDICAP OF NATIVE LIVER IN RAT HALTx 229
0.014) and 28 (p < 0.001). Similarly to serum
TBil, the highest ALAT values of group 5 on
day 3 were again due to the rats that later died
of infectious complications. When those values
were excluded, the differences were no longer
significant on day 3 but remained significant on
day 21 (p 0.008) and 28 (p < 0.001).
Autopsy and Histology
At the end of three months observation period,
all the engrafted livers of the 10 survivors in
group 4 showed atrophy at sacrifice while their
native livers showed normal appearance (Fig. 3a).
The general architecture of those engrafted livers
was altered by fibrosis and ductular metaplasia.
Only a few groups of hepatocytes were present
(Fig. 4a).
On the contrary, in group 5, the engrafted
livers of all but 2 long term survivors appeared
normal macroscopically whereas their native
livers showed clear atrophy (Fig. 3b). The gen-
eral architecture of those engrafted livers was
well preserved without major histological altera-
tions (Fig. 4b). The 2 remaining rats (1
# and 6#)
presented cirrhotic appearance of their en-
grafted livers and the histology revealed sec-
ondary biliary cirrhosis due to sub-obstruction
of their hepaticoduodenostomy.
(a)
DISCUSSION
In the previous studies of rat HALTx, the post-
operative animal survival and serum biochem-
istry were most commonly analysed without
taking into account t.he role of the handicap of
the native liver. In this study, we show for the
first time how these handicaps can differently
influence the post-transplant biochemical param-
eters.
The classical rat model of HALTx includes a
complete shunting of the portal blood away
from the native liver to re-vascularize the en-
grafted liver. In this case, the blood supply of
(b)
FIGURE 3 Autopsy. (a) a rat of group 4 (HALTx with a 68%
PH to handicap the native liver) sacrificed 7 months after the
operation: the engrafted liver (/) atrophied whereas the
native liver had normal appearance; (b) a rat of group 5
(HALTx with a 68% PH and a CBDL to handicap the native
liver) sacrificed 12 months after the operation: the size of the
engrafted liver (/) enlarged and the native liver underwent
complete atrophy. (See Color Plate I).230 Y.-D. FAN et al.
(a) (b)
FIGURE 4 Histological observations. (a) a rat of group 4 (HALTx with a 68% PH to handicap the native liver) sacrificed 7
months after the operation: the general architecture of the engrafted liver was altered by fibrosis (,) and ductular metaplasia
(**). Only a few groups of hepatocytes were present (/) (Trichrome, x 10); (b) a rat of group 5 (HALTx with a 68% PH and a
CBDL to handicap the native liver) sacrificed 12 months after the operation: the general architecture of the engrafted liver was
well preserved and no major alterations were present (HE, x 10).
the native liver is solely given by the hepatic
artery, which corresponds effectively to a PCS
of the liver. It appears that the blood flow of
the hepatic artery can compensate the by-passed
portal blood after a PCS and maintain a
"functioning liver", so that the effects of PCS
do not significantly influence the animal sur-
vival. Without handicap of the native liver, the
engrafted liver is therefore transplanted parallel
with a normal functioning liver. The increased
hepatic blood flow will not be sufficient to
support proper hepatic function if a further
handicap is carried out in the native liver. It is
reported that in the case of a 68% PH added to
an end-to-side PCS, the rat survival does not
exceed 2 days [11]. The results of the present
study confirm this data and show, as would
have been anticipated, that the combination of
a PCS, a 68% PH and a CBDL does even shorten
this survival time. In both these circumstances,
no animal can be kept alive unless an auxiliary
liver graft is transplanted.
The long-term survivors in the HALTx groups
make it possible to perform a comparative study
of the serum biochemistry between the rats bear-
ing different liver handicaps. When the rats
were handicapped only with a 68% PH as in
group 4, ALAT increased to a peak level 1 week
post-transplant but then returned to normal
values after 2 weeks reflecting transitory hepa-
tocellular damage. Both ischemic injury of the
graft caused by preservation and the surgicalHANDICAP OF NATIVE LIVER IN RAT HALTx 231
manipulations of the liver at the time of 68% PH
are responsible for this initial elevation. On
the other hand, TBil of this group, only raised
slightly after the surgery even in the rats that
presented fatal complications. This demon-
strates that in case of a sole 68% PH to handicap
the native liver, either one of the two livers can
still compensate for the functional deficiency of
the other. An additional CBDL to the native liver
will handicap this organ so profoundly that it
can no longer compensate when the engrafted
liver is affected by an acute infectious complica-
tion: TBil sharply increased in these cases
followed by the animal deaths shortly later as
shown in group 5. The "double handicap" of the
native liver is alsO responsible for a second peak
of TBil around 1 month after HALTx. The rats
that developed secondary biliary cirrhosis of the
graft presented the highest values at this time
point, when the exhaustion of the regeneration
potential and thereby the functional failure of
the native liver occurred [19]. The repermeabi-
lisation of the extrahepatic biliary duct of the
native liver may presumably explain the nor-
malisation of serum TBil in the long-term
survivors.
It has been found that long-standing bile
duct obstruction of the native liver impairs the
function of reticuloendothelial system which
might lead to serious post-operative complica-
tions [20, 21]. The rats handicapped with CBDL
(group 5) had indeed a higher incidence of
infection and more pronounced post-operative
weight-loss. Cholestasis induced by CBDL also
inhibits the metabolic functions of liver cells
including mitochondrial function. As conse-
quence, regeneration, capacity of this organ is
compromised [22, 23]. These may be the reasons
why a CBDL together with a 68% PH can affect
the native liver to such a degree that the post-
HALTx animal survival and normal serum
biochemical values depend totally upon the
functionality of the engrafted liver.
HALTx has advantages over OLTx in treating
acute liver failure, inborn errors of metabolism
and, exceptionally, chronic liver diseases with
high operative risk for OLTx. In the case of acute
liver failure, the diseased native liver is expected
to recover while the engrafted liver is providing
functional support. The engrafted liver will then
be removed or left in place to atrophy if the
native liver resumes its proper function [1-3].
For patients with chronic liver diseases, regen-
eration of the engrafted liver and atrophy of
the native liver is the rule after a HALTx [24].
Although up to now no clinical experience with
HALTx to treat patients with inborn errors of
metabolism has been reported, the long term
functionality of both the engrafted and the
native livers should be looked for [4]. In view
of these different situations, it is indeed im-
portant to have a better understanding about the
mechanisms of inter-liver competition and the
right approaches to control or to modify this
process. It is for this purpose, the rat HALTx can
be an interesting model to study the insight of
this phenomenon, even though it does not
replicate the exact clinical situation. It is gen-
erally accepted that proper regeneration of the
liver can only be achieved when the portal vein
is re-vascularized with venous blood or through
arterialization of the portal stump [6,15,25].
Interestingly, the partially resected native liver
can still regain progressively its volume and
function despite the lack of portal blood flow,
whereas the engrafted liver eventually atro-
phies. In case of an additional handicap of the
native liver, by means of a CBDL, the functional
recuperation of the native liver is completely
impaired while the engrafted liver takes over the
function and keeps its normal macroscopic and
microscopic aspects. These results suggest that
besides the known hepatotrophic factors [8,26],
the diseased state of the native liver also
influences the outcome of the inter-liver compe-
tition. Yu and co-workers have shown that the
atrophy of the engrafted liver can be prevented
by its re-arterialisation even when the native
liver is not handicapped [5]. Re-arterialisation of
the graft in the OLTx model reduces biliary232 Y.-D. FAN et aI.
complications, modifies the immunological re-
sponse and improves micro-vascular perfusion
of the graft [27-29]. In the rat model Of HALTx,
these beneficial effects certainly favour the
competitive position of the engrafted liver.
The data of the present study show that in the
rat model of HALTx the different manipulations
on the native liver do influence not only the
post-transplant animal survival but also the
serum biochemical values of the liver. Further-
more, handicap of the native liver limited to a
68% PH will lead to the atrophy of the engrafted
liver, whereas a 68% PH combined with a CBDL
is an handicap that impairs the regeneration
of the native liver. In the latter case, the post-
HALTx survival and normalisation of the serum
biochemistry depend solely upon the viability of
the engrafted liver. Although this model has no
direct similarity with clinical condition, it allows
further approach and understanding to the con-
cept of inter-liver competition.
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COMMENTARY
"The necessity to handicap the recipient’s native
liver in the rat model of heterotopic auxiliary
liver transplantation".
Auxiliary liver transplantation is an attractive
concept in certain clinical situations. These in-
clude acute fulminant liver failure in which
regeneration of the diseased liver potentially
allows withdrawal of immunosuppression with
or without removal of the graft, as well as in
born errors of metabolism without underlying
structural liver abnormalities. The potential role
in patients with cirrhosis is uncertain because of
the very high late incidence of malignant trans-
formation in the native liver. A major problem in
auxiliary transplantation is the competition
between the grafted liver and the host liver
which has caused confusion both experimentally
and clinically. This paper explores the variation
in experimental models of rat auxiliary trans-
plantation and has produced convincing experi-
mental data as to how the native liver should be
handicapped in order to fully explore the
competition between both the native and grafted
liver. This paper is a useful contribution to our
knowledge on this confusing subject and will
help set standards for future rat experimental
studies on this topic. It should be remembered
however that this work is far removed from the
clinical setting and any conclusions reached will
not have any direct applications to clinical
practice.
Mr. JAC Buckels
University Department of Surgery
University of Birmingham
Queen Elizabeth Hospital
Edgbaston
BIRMINGHAM B12 2TH
In this paper Y.-D. Fan and colleagues
investigate several modalities of trauma to the
liver of the rat after which the animal receives an
auxiliary graft, heterotopically placed. Although
their technique of impairment of the native liver
is not similar to the clinical situation (as they
state in the Discussion) it offers an interesting
opportunity to study the physiology of "func-
tional competition" between two livers. Since
the first description of this phenomenon in
rabbits in which one lobe of the liver hyper-
trophied when the other lobe was handicapped
by bile duct of portal vein branch ligation (L.
Schalm et al., Gastroenterology, 1956; 31: 131-
155) a debate started on the importance of the
role of portal venous blood. In a classical paper
Marchioro, Starzel a.o. (Surg Gyn Obst 1965; 121:
17-31) demonstrated the presence of specific
nutrients in portal venous blood, called "hepato-
trophic factors", necessary to maintain the
integrity of the liver and to stimulate compensa-
tory growth after damage to the liver. Although
the true nature of the hepatotrophic factors is
still not elucidated several hormones, growth
factors and cytokines are among them. Fan and
coworkers demonstrated that the native liver
with a dual blood flow is capable of compensa-
tory hyperplasia after 2/3 hepatectomy unless
an extra trauma such as common bile duct
ligation is added. Then, the liver graft supplied
by portal blood only, will benefit from the234 Y.-D. FAN et al.
hepatotrophic factors while the native liver
becomes fibrotic.
It is likely that the upregulation of genes that
express the receptors that bind the different
growth factors occurs in the former situation in
the native liver, while in the more handicap-
ped situation the recipient’s own liver is too da-
maged to up-regulate those gene(s). The growth
factors will then bind to the grafted liver and the
stimulus to proliferate will be exercised in the
graft.
The model as described in the paper enables
further study into the physiology of inter-liver
competition.
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